Conneqt Health Limited Cash Flow Conversion Efficiency
Conneqt Health Limited cash flow conversion efficiency. Based on the latest financial reports, Conneqt Health Limited (CQT) has a cash flow conversion efficiency ratio of 1.844x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-4.53 Million ≈ $-3.21 Million USD) by net assets (AU$-2.46 Million ≈ $-1.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Conneqt Health Limited (2023–2025)
Cash flow conversion efficiency of Conneqt Health Limited from 2023 to 2025. This chart illustrates how Conneqt Health Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Conneqt Health Limited stock price for real-time trading data and today's change.
Conneqt Health Limited Cash Flow Conversion Ratio Explained
Conneqt Health Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Conneqt Health Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Conneqt Health Limited ranked by their cash flow conversion efficiency. Also see Conneqt Health Limited market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Oryx International Growth Fund
LSE:OIG
|
0.001x |
|
Galeo Concept SA
PA:MLGAL
|
N/A |
|
Alaunos Therapeutics Inc
NASDAQ:TCRT
|
-0.460x |
|
Jost AG
MU:JOX
|
N/A |
|
TECH INVEST GROUP ZY-02
F:6N2
|
0.044x |
|
Nobel29 Resources Corp
V:NBLC
|
0.055x |
|
Yowie Group Ltd
AU:YOW
|
-0.091x |
|
Next Mediaworks Limited
NSE:NEXTMEDIA
|
0.009x |
Annual Cash Flow Conversion Efficiency for Conneqt Health Limited (2023–2025)
The table below shows the annual cash flow conversion efficiency of Conneqt Health Limited from 2023 to 2025. Review how financially flexible is Conneqt Health Limited to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$633.50K ≈ $448.24K |
AU$-10.90 Million ≈ $-7.71 Million |
-17.200x | -810.51% |
| 2024-06-30 | AU$4.09 Million ≈ $2.89 Million |
AU$-7.72 Million ≈ $-5.46 Million |
-1.889x | -111.79% |
| 2023-06-30 | AU$-748.40K ≈ $-529.54K |
AU$-12.00 Million ≈ $-8.49 Million |
16.029x | -- |
About Conneqt Health Limited
Conneqt Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffnes… Read more